Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-021665
Filing Date
2022-03-30
Accepted
2022-03-30 19:57:42
Documents
1
Period of Report
2022-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3132
  Complete submission text file 0001209191-22-021665.txt   4460
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877
Business Address
Jones Kristi (Reporting) CIK: 0001843849 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40045 | Film No.: 22788631